EA

Ekhlaque Ahmad

Director Director DIN 10285281
DIN 10285281 First appointment Aug 2023 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2023
Shareholding value Locked Premium profile

About Ekhlaque Ahmad

Data last updated:

Ekhlaque Ahmad has 3 years in corporate governance. Formerly with 1 company, such as Aizenza Biopharmaneutricals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10285281
Primary Designation Director
First Appointment 20 Aug 2023
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director20 Aug 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aizenza Biopharmaneutricals Private Limited
Premium access

Shareholding and investment profile for Ekhlaque Ahmad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ekhlaque Ahmad

Ekhlaque Ahmad has 3 years in corporate governance. Formerly with 1 company, such as Aizenza Biopharmaneutricals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ekhlaque Ahmad is associated with 0 companies as a director.

Ekhlaque Ahmad has expertise in General Business.

Ekhlaque Ahmad has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available